Brown & Brown (BRO) Holder Van Berkom & Associates Has Decreased Its Position; Lourd Capital Has Increased Bristol Myers Squibb Co (BMY) Stake by $1.41 Million

April 18, 2018 - By Adrian Mccoy

Brown & Brown, Inc. (NYSE:BRO) Logo

Lourd Capital Llc increased its stake in Bristol Myers Squibb Co (BMY) by 167.82% based on its latest 2017Q4 regulatory filing with the SEC. Lourd Capital Llc bought 23,159 shares as the company’s stock rose 2.38% while stock markets declined. The institutional investor held 36,959 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.27 million, up from 13,800 at the end of the previous reported quarter. Lourd Capital Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $85.71B market cap company. The stock increased 0.08% or $0.04 during the last trading session, reaching $52.42. About 10.84M shares traded or 44.05% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 18, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Van Berkom & Associates Inc decreased its stake in Brown & Brown Inc (BRO) by 45.38% based on its latest 2017Q4 regulatory filing with the SEC. Van Berkom & Associates Inc sold 501,910 shares as the company’s stock declined 1.08% with the market. The institutional investor held 604,107 shares of the finance company at the end of 2017Q4, valued at $31.09M, down from 1.11 million at the end of the previous reported quarter. Van Berkom & Associates Inc who had been investing in Brown & Brown Inc for a number of months, seems to be less bullish one the $7.26 billion market cap company. The stock decreased 0.08% or $0.02 during the last trading session, reaching $26.29. About 283,143 shares traded. Brown & Brown, Inc. (NYSE:BRO) has risen 18.96% since April 18, 2017 and is uptrending. It has outperformed by 7.41% the S&P500.

Since December 12, 2017, it had 1 buying transaction, and 1 sale for $85,985 activity. $335,172 worth of stock was sold by Lynch Thomas J. Jr. on Tuesday, December 12.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 12 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 80 analyst reports since July 28, 2015 according to SRatingsIntel. Barclays Capital maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, September 9 with “Equal-Weight” rating. Cowen & Co maintained Bristol-Myers Squibb Company (NYSE:BMY) on Monday, September 18 with “Hold” rating. BMO Capital Markets maintained the stock with “Underperform” rating in Friday, July 28 report. The rating was maintained by Credit Suisse with “Neutral” on Friday, October 27. The stock has “Equal Weight” rating by Barclays Capital on Tuesday, December 1. As per Thursday, August 11, the company rating was downgraded by Berenberg. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Thursday, July 14. The rating was downgraded by Jefferies on Monday, October 16 to “Hold”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by UBS on Friday, October 6. The stock has “Sell” rating by BMO Capital Markets on Wednesday, August 16.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.09, from 1.03 in 2017Q3. It turned negative, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Boyd Watterson Asset Management Limited Company Oh reported 3,776 shares. Train Babcock Advisors holds 0.09% or 3,502 shares. Longer Invs stated it has 1.68% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Sfe Invest Counsel invested in 0.22% or 8,735 shares. Budros Ruhlin And Roe reported 22,405 shares. Scotia Cap Incorporated owns 132,300 shares or 0.11% of their US portfolio. Wesbanco Commercial Bank accumulated 1.88% or 452,651 shares. Bb&T Securities Limited Com invested 0.45% in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Crawford Invest Counsel Inc has 0.03% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 17,694 shares. British Columbia Investment Mgmt holds 0.42% or 969,308 shares in its portfolio. Garrison Bradford Assocs has 0.2% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 4,000 shares. New Hampshire-based Charter Trust has invested 0.27% in Bristol-Myers Squibb Company (NYSE:BMY). Cap Mngmt Associate holds 0.32% in Bristol-Myers Squibb Company (NYSE:BMY) or 3,650 shares. Security National Trust accumulated 67,741 shares. Massachusetts-based Rhumbline Advisers has invested 0.33% in Bristol-Myers Squibb Company (NYSE:BMY).

Since March 13, 2018, it had 0 insider purchases, and 1 sale for $7.40 million activity.

Among 14 analysts covering Brown & Brown (NYSE:BRO), 2 have Buy rating, 3 Sell and 9 Hold. Therefore 14% are positive. Brown & Brown had 52 analyst reports since August 24, 2015 according to SRatingsIntel. As per Tuesday, April 3, the company rating was maintained by Morgan Stanley. Morgan Stanley downgraded the shares of BRO in report on Wednesday, January 27 to “Underweight” rating. As per Wednesday, January 27, the company rating was maintained by RBC Capital Markets. On Tuesday, September 15 the stock rating was maintained by Compass Point with “Neutral”. The company was downgraded on Tuesday, September 1 by Zacks. RBC Capital Markets maintained it with “Hold” rating and $4400 target in Monday, June 12 report. The firm has “Neutral” rating by JP Morgan given on Friday, December 16. The firm has “Neutral” rating given on Thursday, July 13 by Citigroup. As per Monday, April 2, the company rating was maintained by Barclays Capital. The firm has “Market Perform” rating by Keefe Bruyette & Woods given on Wednesday, January 13.

Van Berkom & Associates Inc, which manages about $3.36B and $3.07B US Long portfolio, upped its stake in Primoris Svcs Corp (NASDAQ:PRIM) by 244,967 shares to 2.05M shares, valued at $55.81 million in 2017Q4, according to the filing. It also increased its holding in Euronet Worldwide Inc (NASDAQ:EEFT) by 6,178 shares in the quarter, for a total of 773,153 shares, and has risen its stake in Virtu Finl Inc.

Investors sentiment decreased to 0.98 in Q4 2017. Its down 0.18, from 1.16 in 2017Q3. It turned negative, as 18 investors sold BRO shares while 91 reduced holdings. 38 funds opened positions while 69 raised stakes. 97.17 million shares or 2.33% less from 99.49 million shares in 2017Q3 were reported. 757,949 were reported by Deutsche Bank Ag. The Alaska-based State Of Alaska Department Of Revenue has invested 0.01% in Brown & Brown, Inc. (NYSE:BRO). Madison Inv Inc holds 911,363 shares. Castleark Management owns 117,405 shares. California Pub Employees Retirement Sys holds 333,940 shares or 0.02% of its portfolio. Apg Asset Nv holds 0.01% or 84,600 shares. Federated Invsts Pa reported 46,508 shares or 0.01% of all its holdings. Fenimore Asset Mngmt Incorporated reported 1.44 million shares. Kbc Group Nv owns 0.06% invested in Brown & Brown, Inc. (NYSE:BRO) for 141,790 shares. Los Angeles Capital Mngmt And Equity Research Inc reported 37,350 shares. Keybank Natl Association Oh accumulated 39,597 shares. Tci Wealth Advisors Incorporated holds 0% or 194 shares. Pub Employees Retirement Sys Of Ohio owns 55,691 shares for 0.01% of their portfolio. Carroll Financial Assocs Incorporated has 0% invested in Brown & Brown, Inc. (NYSE:BRO). Rhumbline Advisers stated it has 283,983 shares or 0.03% of all its holdings.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts